|
advertisement
Eskalith CR
| Generic Name: | lithium carbonate - slow release |
| Company: | GlaxoSmithKline |
| Web Site: | www.gsk.com/ |
| Country: | USA |
| |
 |
| Description: | Eskalith CR is a scored tablet containing lithium carbonate, 450 mg. They release a portion of the lithium carbonate initially and then gradually release the remainder. |
| |
| Indications: | Eskalith is indicated in the treatment of manic episodes of bipolar disorder (manic-depressive illness). It is shown that maintenance therapy prevents and/or diminishes the intensity of future manic episodes.
Revised April 2009 |
| |
|
|
|
|
advertisement
|
|
 |
